Dear reader, the pharmaceutical industry plays a crucial role in protecting human health, which necessitates stringent ...
The "The Pharma Mini MBA Training Course (Mar 18th - Mar 20th, 2026)" training has been added to ResearchAndMarkets.com's offering.Working in the highly competitive pharmaceutical industry, with ...
December 31, 2025 – PRESSADVANTAGE – As pharmaceutical development becomes increasingly global and highly regulated, pharmacovigilance translation has moved from a supporting function to a central ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
American pharmaceutical firm Inotiv is notifying thousands of people that their personal information was stolen in an August 2025 ransomware attack. Inotiv is an Indiana-based contract research ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
New translational research characterizing potential molecular pathways associated with sensitivity to dordaviprone and exploring how targeted combination strategies may help to enhance response.
Corbus Pharmaceuticals is continuing to march forward with their Nectin-4 ADC, with recent data showcasing impressive tolerability in particular. A recent fundraising for around $75 million was a ...
For more than 25 years, my work has revolved around one guiding principle: quality. In the life sciences sector, safeguarding data integrity, compliance and ethical practices has never been optional.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is one of the top long-term biotechnology stocks to buy. On October 17, Tonix Pharmaceuticals (NASDAQ:TNXP) presented encouraging preclinical data for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results